Study Shows Early Treatment With Hydroxychloroquine May Have Spared Many Deaths From COVID

A study published by the Brownstowne Institute confirms what many conservatives have argued from the start: President Donald Trump was right about the early treatment of COVID-19 with hydroxychloroquine.

The findings lend credibility to his insistence that the drug could play a critical role in combating the virus when used promptly and appropriately.

Dr. Peter McCullough, a renowned physician and outspoken advocate for medical freedom, sees even broader potential for hydroxychloroquine.

“Given the high fatality rate of H5N1, it is essential to explore every potential treatment,” McCullough says.

“In a world where pandemics can strike without warning, having the right tools at your fingertips can mean the difference between severe illness and a quick recovery,” he continued.

According to Dr. McCullough, the drug’s antiviral properties make it a promising candidate for treating other viral threats, including bird flu (H5N1). While human cases of H5N1 remain rare, he stresses the importance of being prepared, given the unpredictable nature of global viral outbreaks.

For many, this study underscores the need for open dialogue and exploration of early treatment options in public health crises. It also serves as a reminder of the importance of standing up for common-sense solutions, even when they are met with skepticism from establishment figures or the mainstream media.